Remicade Biosimilars An Overview of Safety and Efficacy

added blog Other

2024-12-15 07:20:59 -

Infliximab and BiosimilarsRemicade (infliximab) is a biologic drug used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis and psoriasis. It was first approved by the U.S. Food and Drug Administration (FDA) in 1998 and works by blocking tumor necrosis factor-alpha (TNFα), a protein involved in inflammation. As the patent for Infliximab expired...

0 Comments 0 Shares 64 Views 0 Reviews